![Andre Aarøen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andre Aarøen active positions
Companies | Position | Start | End |
---|---|---|---|
Flåmsbrygga Hotell AS
![]() Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Chairman | - | - |
Defibrio AS
![]() Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Chairman | - | - |
Career history of Andre Aarøen
Statistics
International
Norway | 3 |
Operational
Chairman | 2 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Flåmsbrygga Hotell AS
![]() Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Consumer Services |
Defibrio AS
![]() Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Health Technology |
- Stock Market
- Insiders
- Andre Aarøen
- Experience